Genedx Share Price (NASDAQ: WGS)

$129.52

▲

0.52

(0.4%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Genedx Stock chart to analyse performance

Genedx stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$128.50
Today's High:$130.36
$129.52
0.79%
Downside
Day's Volatility :1.43%
Upside
0.64%
52 Weeks Low:$28.86
52 Weeks High:$130.70
$129.52
77.72%
Downside
52 Weeks Volatility :77.92%
Upside
0.9%

Genedx Stock Returns

Period	Genedx Holdings Corp	Index (Russel 2000)
3 Months	74.68%	0.0%
6 Months	37.24%	0.0%
1 Year	321.38%	0.0%
3 Years	12970.56%	-4.1%

Genedx Holdings Corp Key Stats

Check Genedx key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$129.0
Open	$128.97
Today's High	$130.36
Today's Low	$128.5
Market Capitalization	$3.7B
Today's Volume	$441.3K
52 Week High	$130.695
52 Week Low	$28.86
Revenue TTM	$362.3M
EBITDA	$29.6M
Earnings Per Share (EPS)	$0.08
PE Ratio	1612.5
Profit Margin	0.39%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	0.6%

Stock Returns calculator for Genedx Stock including INR - Dollar returns

The Genedx stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Genedx investment value today

Current value as on today

₹4,26,762

Returns

₹3,26,762

(+326.76%)

Returns from Genedx Stock

₹3,21,477 (+321.48%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Genedx Stock

84.62%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Investment in Genedx Shares from India has grown by 84.62% over the past 30 days, indicating increased transactional activity.

111%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Genedx Stock from India on INDmoney has increased by 111% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Genedx Stock

Rating

Trend

Buy

62%Buy

37%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Genedx(by analysts ranked 0 to 5 stars)

Genedx Share Price Target

What analysts predicted

Downside of 10.99%

Target:

$115.29

Current:

$129.52

Genedx share price target is $115.29, a slight Downside of 10.99% compared to current price of $129.52 as per analysts' prediction.

Genedx Stock Insights

Price Movement
In the last 3 years, WGS stock has moved up by 12595.1%
Increasing Revenue
Revenue is up for the last 2 quarters, 87.11M → 102.69M (in $), with an average increase of 15.2% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -6.52M → 10.80M (in $), with an average increase of 160.4% per quarter

Genedx Holdings Corp Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$196.2M	-
Net Income	$-29.7M	-
Net Profit Margin	-15.14%	-

	FY20	Y/Y Change
Revenue	$179.3M	↓ 8.59%
Net Income	$-241.3M	↑ 712.48%
Net Profit Margin	-134.58%	↓ 119.44%

	FY21	Y/Y Change
Revenue	$212.2M	↑ 18.33%
Net Income	$-245.4M	↑ 1.68%
Net Profit Margin	-115.64%	↑ 18.94%

	FY22	Y/Y Change
Revenue	$234.7M	↑ 10.6%
Net Income	$-549.0M	↑ 123.72%
Net Profit Margin	-233.91%	↓ 118.27%

	FY23	Y/Y Change
Revenue	$202.6M	↓ 13.69%
Net Income	$-175.8M	↓ 67.98%
Net Profit Margin	-86.77%	↑ 147.14%

	FY24	Y/Y Change
Revenue	$305.5M	↑ 50.79%
Net Income	$-52.3M	↓ 70.25%
Net Profit Margin	-17.12%	↑ 69.65%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$62.4M	↑ 8.72%
Net Income	$-20.2M	↓ 21.47%
Net Profit Margin	-32.42%	↑ 12.47%

	Q2 FY24	Q/Q Change
Revenue	$70.5M	↑ 12.96%
Net Income	$-29.2M	↑ 44.14%
Net Profit Margin	-41.37%	↓ 8.95%

	Q3 FY24	Q/Q Change
Revenue	$76.9M	↑ 9.02%
Net Income	$-8.3M	↓ 71.51%
Net Profit Margin	-10.81%	↑ 30.56%

	Q4 FY24	Q/Q Change
Revenue	$95.6M	↑ 24.41%
Net Income	$5.4M	↓ 165.42%
Net Profit Margin	5.69%	↑ 16.5%

	Q1 FY25	Q/Q Change
Revenue	$87.1M	↓ 8.91%
Net Income	$-6.5M	↓ 220.06%
Net Profit Margin	-7.49%	↓ 13.18%

	Q2 FY25	Q/Q Change
Revenue	$102.7M	↑ 17.88%
Net Income	$10.8M	↓ 265.55%
Net Profit Margin	10.53%	↑ 18.02%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$82.8M	-

	FY20	Y/Y Change
Profit	$4.0M	↓ 95.14%

	FY21	Y/Y Change
Profit	$-16.6M	↓ 512.37%

	FY22	Y/Y Change
Profit	$-26.8M	↑ 61.13%

	FY23	Y/Y Change
Profit	$60.6M	↓ 326.62%

	FY24	Y/Y Change
Profit	$194.4M	↑ 220.67%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$33.0M	↑ 28.95%

	Q2 FY24	Q/Q Change
Profit	$38.5M	↑ 16.87%

	Q3 FY24	Q/Q Change
Profit	$47.8M	↑ 24.1%

	Q4 FY24	Q/Q Change
Profit	$66.2M	↑ 38.42%

	Q1 FY25	Q/Q Change
Profit	$58.5M	↓ 11.67%

	Q2 FY25	Q/Q Change
Profit	$70.9M	↑ 21.25%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-18.7M	-
Investing Cash Flow	$-15.5M	-
Financing Cash Flow	$148.0M	-

	FY20	Y/Y Change
Operating Cash Flow	$-93.1M	↑ 397.27%
Investing Cash Flow	$-32.0M	↑ 106.87%
Financing Cash Flow	$129.1M	↓ 12.81%

	FY21	Y/Y Change
Operating Cash Flow	$-190.4M	↑ 104.49%
Investing Cash Flow	$-20.8M	↓ 34.99%
Financing Cash Flow	$493.7M	↑ 282.57%

	FY22	Y/Y Change
Operating Cash Flow	$-319.2M	↑ 67.59%
Investing Cash Flow	$-141.3M	↑ 579.91%
Financing Cash Flow	$197.3M	↓ 60.04%

	FY23	Y/Y Change
Operating Cash Flow	$-180.1M	↓ 43.56%
Investing Cash Flow	$-43.7M	↓ 69.06%
Financing Cash Flow	$186.2M	↓ 5.61%

	FY24	Y/Y Change
Operating Cash Flow	$-28.5M	↓ 84.18%
Investing Cash Flow	$-30.1M	↓ 31.09%
Financing Cash Flow	$44.2M	↓ 76.29%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-16.4M	↓ 45.03%
Investing Cash Flow	$843.0K	↓ 117.33%
Financing Cash Flow	$-438.0K	↓ 100.93%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-4.5M	↓ 72.55%
Investing Cash Flow	$-22.7M	↓ 2792.88%
Financing Cash Flow	$-391.0K	↓ 10.73%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-4.4M	↓ 2.44%
Investing Cash Flow	$-7.8M	↓ 65.84%
Financing Cash Flow	$14.0M	↓ 3672.38%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-3.2M	↓ 27.58%
Investing Cash Flow	$-519.0K	↓ 93.31%
Financing Cash Flow	$31.0M	↑ 122.1%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$10.2M	↓ 419.89%
Investing Cash Flow	$-9.4M	↑ 1712.72%
Financing Cash Flow	$13.7M	↓ 55.78%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$10.4M	↑ 2.34%
Investing Cash Flow	$-36.4M	↑ 286.37%
Financing Cash Flow	$346.0K	↓ 97.48%

Genedx Technicals Summary

Sell

Neutral

Buy

Genedx is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Genedx Holdings Corp Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Genedx Holdings Corp	27.45%	37.24%	321.38%	12970.56%	1221.33%
Agilent Technologies Inc.	10.74%	-0.51%	-9.55%	-2.51%	24.3%
Idexx Laboratories, Inc.	20.6%	47.74%	37.7%	84.56%	62.07%
Thermo Fisher Scientific, Inc.	6.38%	-5.93%	-18.77%	-10.56%	13.57%
Danaher Corp.	4.47%	0.1%	-22.08%	-24.82%	-1.19%
Iqvia Holdings Inc.	4.47%	3.11%	-23.4%	-9.93%	15.42%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Genedx Holdings Corp	1612.5	1612.5	NA	1.74	0.01	0.01	NA	9.65
Agilent Technologies Inc.	29.29	29.29	1.84	5.57	0.2	0.08	0.0	22.46
Idexx Laboratories, Inc.	53.78	53.78	4.84	12.6	0.65	0.23	NA	18.2
Thermo Fisher Scientific, Inc.	28.33	28.33	1.99	22.49	0.13	0.05	0.0	133.77
Danaher Corp.	43.68	43.68	2.06	7.77	0.07	0.04	0.01	73.1
Iqvia Holdings Inc.	27.61	27.61	1.08	11.87	0.2	0.05	NA	33.99

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Genedx Holdings Corp	Buy	$3.7B	1221.33%	1612.5	0.39%
Agilent Technologies Inc.	Buy	$35.7B	24.3%	29.29	17.97%
Idexx Laboratories, Inc.	Buy	$51.8B	62.07%	53.78	24.41%
Thermo Fisher Scientific, Inc.	Buy	$184.9B	13.57%	28.33	15.24%
Danaher Corp.	Buy	$147.0B	-1.19%	43.68	14.21%
Iqvia Holdings Inc.	Buy	$32.4B	15.42%	27.61	7.88%

About Genedx Holdings Corp

GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.

Organization	Genedx
Employees	1000
CEO	Ms. Katherine A. Stueland
Industry	Healthcare

Key Management of Genedx Holdings Corp

Name	Title
Ms. Katherine A. Stueland	President, CEO & Director
Mr. Kevin Feeley CPA	Chief Financial Officer
Dr. Bryan M. Dechairo Ph.D.	Chief Operating Officer
Ms. Heidi C. Chen J.D.	Chief Legal Officer
Ms. Jami Biliboaca	Head of People Strategy
Ms. Melanie Duquette	Chief Growth Officer
Dr. Martin G. Reese Ph.D.	President of Fabric Genomics

Important FAQs about investing in WGS Stock from India :

What is Genedx share price today?

Genedx share price today is $129.52 as on August 30, 2025 at 1:29 am IST at the close of the market. Genedx share today touched a day high of $130.36 and a low of $128.50.

What is the 52 week high and 52 week low for Genedx share?

Genedx share touched a 52 week high of $130.70 and a 52 week low of $28.86. Genedx stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $129.52, lower by 0.9% versus the 52 week high.

How to invest in Genedx Stock (WGS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Genedx on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Genedx Shares that will get you 0.0116 shares as per Genedx share price of $129.52 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Genedx Stock (WGS) from India?

Indian investors can start investing in Genedx (WGS) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Genedx stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Genedx share’s latest price of $129.52 as on August 30, 2025 at 1:29 am IST, you will get 0.0772 shares of Genedx. Learn more about fractional shares .

What are the returns that Genedx has given to Indian investors in the last 5 years?

Genedx stock has given 1221.33% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?